Theracryf Plc (TCF.L)

GBp 0.53

(0.0%)

EBITDA Summary of Theracryf Plc

Theracryf Plc's latest annual EBITDA in 2023 was -3.54 Million GBP , up 29.82% from previous year.
Theracryf Plc's latest quarterly EBITDA in 2023 FY was N/A , up 29.82% from previous quarter.
Theracryf Plc reported an annual EBITDA of -4.99 Million GBP in 2022, down -59.28% from previous year.
Theracryf Plc reported an annual EBITDA of -3.15 Million GBP in 2021, up 0.35% from previous year.
Theracryf Plc reported a quarterly EBITDA of -1.45 Million GBP for 2023 Q2, up 49.48% from previous quarter.
Theracryf Plc reported a quarterly EBITDA of -2.1 Million GBP for 2023 Q4, down -44.67% from previous quarter.

Annual EBITDA Chart of Theracryf Plc (2023 - 2016)

Historical Annual EBITDA of Theracryf Plc (2023 - 2016)

Year	EBITDA	EBITDA Growth
2023	-3.54 Million GBP	29.82%
2022	-4.99 Million GBP	-59.28%
2021	-3.15 Million GBP	0.35%
2020	-3.19 Million GBP	-1.95%
2019	-3.14 Million GBP	-0.84%
2018	-3.09 Million GBP	-3.09%
2017	-3 Million GBP	17.12%
2016	-3.62 Million GBP	0.0%

Year	EBITDA	EBITDA Growth
2023 FY	- GBP	29.82%
2023 Q2	-1.45 Million GBP	49.48%
2023 Q4	-2.1 Million GBP	-44.67%
2022 Q4	-2.87 Million GBP	-29.84%
2022 FY	- GBP	-59.28%
2022 Q2	-2.21 Million GBP	-33.27%
2021 Q2	-1.51 Million GBP	-12.14%
2021 FY	- GBP	0.35%
2021 Q4	-1.66 Million GBP	-9.7%
2020 FY	- GBP	-1.95%
2020 Q4	-1.35 Million GBP	33.71%
2020 Q2	-2.03 Million GBP	-31.74%
2019 Q4	-1.54 Million GBP	0.0%
2019 FY	- GBP	-0.84%
2018 FY	- GBP	-3.09%
2017 FY	- GBP	17.12%
2016 FY	- GBP	0.0%

Peer EBITDA Comparison of Theracryf Plc

Name	EBITDA	EBITDA Difference